Updates from around the Mölnlycke world

Zlatko Rihter has been appointed President and CEO of the medical solutions company, Mölnlycke Health Care AB.

AstraZeneca’s BioVentureHub announced today that it has established a new collaboration with Mölnlycke, a global medtech company headquartered in...

On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility. The facility has a tenor of five years with two...

24 September 2020:  With surgeons and nurses working to clear the elective backlog from coronavirus, a new global survey has revealed they are suffering...

On World Smile Day, 2 October, in collaboration with our global charity Operation Smile, we are encouraging our employees, partners and customers to sen...

Gothenburg, Sweden. 15 October, 2020 – Mölnlycke is celebrating World Handwashing Day with the global launch of the innovative Biogel® PI UltraTouch® S...

New report shows Granulox ® (Mölnlycke), an innovative topical haemoglobin spray, is a cost-effective therapy in chronic wound care management as adjunc...

With a strong track record of financial leadership in publicly listed Swedish companies Susanne Larsson will join the company as Group Chief Financial...

Mölnlycke, a world-leading medical solutions company, successfully launched on 28 August a EUR 500 million senior unsecured bond off its newly establish...

Today, Zlatko Rihter assumes his position as President and CEO of Mölnlycke.

The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region

The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....

Aashima Gupta, Global Director of Healthcare Industry Solutions at Google Cloud , has been elected Board Member at Mölnlycke AB as of 1 March 2023.  

Despite advances in surgical techniques, still today, surgical site complications such as SSI remain a challenge in clinical practice and a significant...

From strategy to implementation, Mölnlycke ® is partnering with ENGIE in our transformation to become a global leader in sustainable healthcare.

New Wounds International article focuses on the impact of venous leg ulcers on patient quality of life and looks at considerations for dressings selecti...

Robust global clinical trial included 13,000+ patients; results published in The Lancet

Pressure ulcers continue to place a huge burden on both patients and healthcare systems and as long as there's scope to reduce that burden, Mölnlycke wi...

From May 31st to June 2nd, the ERAS Society, which was founded on the mission to develop perioperative care and to improve recovery through research,...

We are pleased to announce that Mölnlycke will attend the 14 th  APBC (Asian Pacific Burn Congress) in Chongqing of China on September 13 - 16, 2023.

Global s urvey of  510  surgeons  is  first of its kind ;   81%   believe  high quality gloves impact patient outcomes ;     92%  agree d  that high...

The Medical Device Regulation (MDR) – which was due to enter into force in May this year –will replace the Medical Device Directive in Europe and is muc...

Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and plan...

Mölnlycke expects to be MDR compliant in line with the original timeline - but supports the proposed extended MDR transition period in order to protect...

In our press room you can find the latest press releases as well as our logotype and images for download.

The Science Based Targets initiative (SBTi) has validated that the greenhouse gas (GHG) emission reduction targets submitted by Mölnlycke Health Care...

What will healthcare look like in the next 10 years? What will it look like next year? 

A decade ago, the antimicrobial foam exudate transfer dressing Mepilex® Transfer Ag was introduced as a new option for HCPs and patients in wound...

How can innovation help detect wound infection and possibly reduce unnecessary use of antibiotics in wound care? Watch as R&D director Anders Dahlberg...

A supplement, authored by Phil Davies, Senior Global Medical Affairs Manager at Mölnlycke Healthcare, presenting a literature review on Closed Incision...

Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).

In its pursuit of sustainable growth and to meet future demands for supply and sustainability Mölnlycke has inaugurated a new surgical gloves factory in...

Mölnlycke ® Health Care has been awarded the 2023 Enlightened Growth Leadership Award by The Frost & Sullivan Institute for commitment to creating a...

Mölnlycke’s haemoglobin spray Granulox ® has been awarded the prestigious Prix Galien for best new medical device in Belgium and Luxembourg.

Last spring, Mölnlycke Health Care announced that they will move to an entire new headquarter in GoCo Health Innovation City. The 16,000 square meter...

Six Mölnlycke volunteers just came back from the first Surgical Medical Programme in Cebu, the Philippines, where a cleft care centre of excellence is...

Artist Maria Koijck challenged the healthcare industry with art project based on waste from own breast cancer surgery Mölnlycke Health Care responded by...

Karl-Henrik Sundström, professional board member and, among others, former CEO of Stora Enso and CFO of Ericsson, has been appointed new Chair of the...

Gothenburg, 31 August 2023: Mölnlycke, a world-leading medtech company, has successfully raised EUR 400M in the corporate bond market under its Euro...

Mölnlycke ® is investing EUR 50 million in a new plant in Kulim, Malaysia, to meet future demand for high-quality surgical gloves. The new plant will...

From 26-29 September 2018, Mölnlycke was present at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic...

Mölnlycke now moves to a new structure based on business areas, driven from a customer centric perspective with an end-to-end responsibility. At the sam...

The industry community is ideally placed to ensure Sweden’s resilience for the future. Saab AB, ABB AB, AB Volvo and Mölnlycke AB are partnering to help...

Today, Mölnlycke joins the groundbreaking ceremony marking the start of construction for their future headquarters at GoCo Health Innovation City. “This...

Tina Westerberg and Daniel Tsang work at Mölnlycke´s R&D department. When the Swedish healthcare needed help, they both stepped in.

Last month saw the ground-breaking ceremony for Mölnlycke’s new surgical glove factory in Malaysia. The company is increasing its manufacturing capacity...

The 2020 report shows the company achieved strong organic sales growth, partly through supplying personal protective equipment (PPE) during the COVID-19...

Watch the recent Mölnlycke Talks Online round table discussion, where we catch up with our expert panel who shares their reflections on events since we...

The company’s most recent Sustainability Report is out now, outlining our performance against our sustainability targets and approach for the future.

Despite the fact that Mölnlycke has introduced a number of measures, the current global macro-economic challenges are now forcing us to raise prices....

World-leading medical solutions company Mölnlycke is setting up a centre for cleft care in the Philippine city of Cebu with its long-term charity partne...

Pawlak, U., Davies, P., Wounds International 2022 

During an extra general meeting on 16 March 2021, the Board of Mölnlycke appointed Johan Torgeby and Kristina Willgård as new Board members.

Mölnlycke’s integrated Annual and Sustainability Report is now available for download, outlining the company’s results and performance in 2021.

Facial Pressure Injuries (PI) caused by extended use of medical devices have long been a burden for patients and difficult for health care professionals...

At Molnlycke, we value making a real, sustainable difference to all patients and healthcare professionals globally. Join us for a round table discussion...

The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a silver medal for our focus on...

We are deeply concerned about the current security situation in Europe and fully acknowledge the gravity and tragedy of events in Ukraine. While Mölnlyc...

To support Mölnlycke’s next level of growth, and further develop the way we work in the Finance, IT and People/HR functions, Mölnlycke is establishing a...

In late 2024 Mölnlycke will relocate to brand new headquarters in GoCo Health Innovation City in Mölndal. The new headquarters will have a total area of...

When the Swedish healthcare system sent out an urgent appeal for support with the pandemic, Mölnlycke and its employees sprang into action.

We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home. Now we are gearing up for a...

Mölnlycke has recently been made aware of alleged deviations from our Supplier Code of Conduct by one of our Chinese suppliers. We take these reports ve...

7 December 2020, Milton Keynes, UK. Mölnlycke announces the launch of a new UK distribution centre, strengthening customers’ access to quality Mölnlycke...

Nordic Health Innovation: From realisation to business  16th Park Annual 2021 takes place on October 7, 10:00 – 15:00 CET and can be attended virtually....

Mölnlycke, a world-leading medical solutions company, successfully launched on 2 of December a EUR 400 million senior unsecured bond under its EMTN (Eur...

Join us for a roundtable discussion on sustainability in the OR and balancing patient and healthcare provider care with care for the environment. Watch...

Mölnlyckes försäljning växte under årets andra kvartal med 1 % i konstant valuta. Såväl Wound Care som Surgical växte, dock med en lägre tillväxttakt än...

We are pleased to announce the successful closing and signing of a EUR 350,000,000 Multicurrency Revolving Credit Facility (the “Facility”) for Mölnlyck...

At Mölnlycke ® , we value connecting with healthcare professionals from around the world. Join us for a roundtable discussion. Watch on-demand

Welcome to our popular Mölnlycke Talks Online - 'Re-opening Operating Theatres: Navigating the post Covid-19 elective surgery backlog. December 1, 19:00...

Gothenburg – 24 July 2020 Barry McBride, EVP Gloves, Antiseptics and Global R&D, will take on the role as interim CEO as of 1 August and until the new...

Welcome to our popular Mölnlycke Talks Online - 'Covid: a catalyst to improve patient engagement. Rethink wound care'. November 23, 7:00PM CET.

Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation.

Pressure injuries (PI) continue to present substantial clinical challenges to health care professionals and place a huge economic burden on health care...

The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...

Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...

Lower-extremity and diabetic foot wound care take center stage at International Symposium on the Diabetic Foot (ISDF), The Hauge, 10-13 May 2023 

EWMA has been the largest European wound care congress for a long time. Now we are entering a new era in which EWMA takes center stage as an important...